Head-to-head · Value Score
CoreAge Rx vs Arc-1
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Arc-1 a 73. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameArc-1
#168 · Grade C+ · Watch List
Est. first month
From $199.99/mo (compounded)
Save ~85% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 73 — an est. $99/mo first month, with no teaser step-up baked in. Arc-1 isn't out of it: Someone on a low dose who will re-price the program before each step up.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Arc-1 |
|---|---|---|
| Value Score | 93 (A+) | 73 (C+) |
| Est. first month | $99/mo | From $199.99/mo (compounded) |
| Save vs brand-name | ~89% | ~85% |
| Semaglutide | $99/mo | From $199.99/mo (compounded) |
| Tirzepatide | $149/mo | From $199.99/mo (compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Arc-1
Arc-1 sells compounded semaglutide and tirzepatide from $199.99 a month as per-dose purchases, inside a broader longevity storefront split by men's and women's programs.
Why it's a deal
- Displays a LegitScript certification and states it works with US-licensed pharmacies and board-certified physicians
- Both molecules open at the same figure, $199.99, so the choice between them is clinical rather than financial at the entry dose
- HIPAA compliance is stated explicitly alongside the clinical claims
- Prices are on the storefront rather than behind an intake
The fine print
- Pricing is per dose, so the cost climbs every time you titrate up rather than holding flat
- No legal entity name or business address is disclosed
- The states it serves are not published, and no clinicians or pharmacy partners are named
- GLP-1s sit inside a longevity catalog rather than being the specialism
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Arc-1.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.